tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Keratosis, Actinic D055623 3 associated lipids
Invasive Pulmonary Aspergillosis D055744 1 associated lipids
Latent Tuberculosis D055985 1 associated lipids
Netherton Syndrome D056770 1 associated lipids
Leukoencephalopathies D056784 3 associated lipids
Central Serous Chorioretinopathy D056833 1 associated lipids
Thrombotic Microangiopathies D057049 1 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Candidiasis, Invasive D058365 2 associated lipids
End Stage Liver Disease D058625 1 associated lipids
Retrognathia D063173 1 associated lipids
Drug-Related Side Effects and Adverse Reactions D064420 3 associated lipids
Scorpion Stings D065008 1 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Fischer L et al. Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study. 2015 Transplantation pmid:26151607
Spolidorio LC et al. The long-term administration of calcineurin inhibitors decreases antioxidant enzyme activity in the rat parotid and submandibular salivary glands. 2015 Life Sci. pmid:26006038
Ali H et al. Mycophenolate mofetil-based salvage as acute GVHD prophylaxis after early discontinuation of tacrolimus and/or sirolimus. 2015 Bone Marrow Transplant. pmid:25365064
Pulk RA et al. Multigene predictors of tacrolimus exposure in kidney transplant recipients. 2015 Pharmacogenomics pmid:26067485
Koreth J et al. A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial. 2015 Biol. Blood Marrow Transplant. pmid:26055298
Sikma MA et al. Pharmacokinetics and Toxicity of Tacrolimus Early After Heart and Lung Transplantation. 2015 Am. J. Transplant. pmid:26053114
Rozman Peterka T et al. Solid state compatibility study and characterization of a novel degradation product of tacrolimus in formulation. 2015 J Pharm Biomed Anal pmid:25804434
Pardi C and Oltean M An unusual case of red blood cell immunisation following liver transplantation. 2015 Blood Transfus pmid:26057497
Chen YB et al. Phase II Trial of Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma. 2015 Biol. Blood Marrow Transplant. pmid:26009261
Revollo J Update on the clinical utility of once-daily tacrolimus in the management of transplantation. 2015 Drug Des Devel Ther pmid:26005334
Qasim W et al. Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient. 2015 J. Hepatol. pmid:25308176
Cortes X et al. Successful use of infliximab and tacrolimus in a patient with Crohn's disease. 2015 Int J Clin Pharmacol Ther pmid:25997551
Chan TM Treatment of severe lupus nephritis: the new horizon. 2015 Nat Rev Nephrol pmid:25421826
Fussner LA et al. Cardiovascular disease after liver transplantation: When, What, and Who Is at Risk. 2015 Liver Transpl. pmid:25880971
Clark SL et al. Making every drop count for pediatric kidney transplant patients. 2015 Hosp Pediatr pmid:25934814
de Sandes-Freitas TV et al. Subclinical Lesions and Donor-Specific Antibodies in Kidney Transplant Recipients Receiving Tacrolimus-Based Immunosuppressive Regimen Followed by Early Conversion to Sirolimus. 2015 Transplantation pmid:25929604
Cheng S and Rodier F Manipulating senescence in health and disease: emerging tools. 2015 Cell Cycle pmid:25928330
Hricik DE et al. Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients. 2015 J. Am. Soc. Nephrol. pmid:25925687
Falloon K et al. Characterization of the FKBP12-Encoding Genes in Aspergillus fumigatus. 2015 PLoS ONE pmid:26366742
Goldthorpe H et al. Occlusive lung arterial lesions in endothelial-targeted, fas-induced apoptosis transgenic mice. 2015 Am. J. Respir. Cell Mol. Biol. pmid:25879383
Chapron B et al. Reversible, time-dependent inhibition of CYP3A-mediated metabolism of midazolam and tacrolimus by telaprevir in human liver microsomes. 2015 J Pharm Pharm Sci pmid:25877445
Nashan B et al. Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial. 2015 Trials pmid:25873064
Ramachandran R et al. Chronic nephrotoxicity limits successful use of Tacrolimus in the management of adult steroid-dependent minimal change disease. 2015 Nephrology (Carlton) pmid:25872662
Zijlstra LE et al. [Heart transplantation in the 21st century in Netherlands: improved survival in the last decade]. 2015 Ned Tijdschr Geneeskd pmid:26648576
Dave V et al. Managing psychosis in a renal transplant recipient with bipolar affective disorder and allograft rejection. 2015 Nephrology (Carlton) pmid:25807849
Hlavaty KA et al. Cellular and molecular targeting for nanotherapeutics in transplantation tolerance. 2015 Clin. Immunol. pmid:25805659
La Placa M et al. Disfiguring papular sarcoidosis of the face: dramatic improvement with pimecrolimus. 2015 J Eur Acad Dermatol Venereol pmid:25073484
Rahman Z et al. Comparison of X-ray powder diffraction and solid-state nuclear magnetic resonance in estimating crystalline fraction of tacrolimus in sustained-release amorphous solid dispersion and development of discriminating dissolution method. 2015 J Pharm Sci pmid:25753829
Garritsen FM et al. Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres. 2015 J Eur Acad Dermatol Venereol pmid:25752497
Qian G et al. Successful treatment of recalcitrant granulomatous rosacea with oral thalidomide and topical pimecrolimus. 2015 J. Dermatol. pmid:25753523
Pennington CA et al. Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients. 2015 Pharmacotherapy pmid:26234282
Wu D et al. BK Virus-Associated Nephropathy with Plasma Cell-Rich Infiltrates Treated by Bortezomib-Based Regimen. 2015 Exp Clin Transplant pmid:25748726
Tachibana T et al. Successful Engraftment and Durable Graft-versus-host Disease Control with Haploidentical Peripheral Blood and a Short-term Conditioning Regimen for Primary Graft Failure. 2015 Intern. Med. pmid:26521905
Margolis DJ et al. Association Between Malignancy and Topical Use of Pimecrolimus. 2015 JAMA Dermatol pmid:25692459
Shuker N et al. Intra-patient variability in tacrolimus exposure: causes, consequences for clinical management. 2015 Transplant Rev (Orlando) pmid:25687818
Fan DM et al. Successful ABO-incompatible living-related intestinal transplantation: a 2-year follow-up. 2015 Am. J. Transplant. pmid:25808777
Kawakami K et al. Effects of oral tacrolimus as a rapid induction therapy in ulcerative colitis. 2015 World J. Gastroenterol. pmid:25684955
Al Gain M et al. [Sirolimus-induced lymphedema in a kidney-transplant recipient: Partial recovery after changeover to tacrolimus]. 2015 Ann Dermatol Venereol pmid:25683011
Matsushima M et al. [A case of anti-PL7 antibody positive myositis and a clinical and pathological review of the anti-synthetase syndrome]. 2015 Rinsho Shinkeigaku pmid:26458569
Kim S et al. Reduction of increased calcineurin activity rescues impaired homeostatic synaptic plasticity in presenilin 1 M146V mutant. 2015 Neurobiol. Aging pmid:26455952
Almeida-Corrêa S et al. Calcineurin inhibition blocks within-, but not between-session fear extinction in mice. 2015 Learn. Mem. pmid:25691516
Luo X et al. Evaluation of 6β-Hydroxycortisol and 6β-Hydroxycortisone as Biomarkers for Cytochrome P450 3A Activity: Insight into Their Predictive Value for Estimating Oral Immunosuppressant Metabolism. 2015 J Pharm Sci pmid:26150050
Herbst S et al. Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus. 2015 EMBO Mol Med pmid:25637383
Cuellar-Rodriguez J et al. Matched related and unrelated donor hematopoietic stem cell transplantation for DOCK8 deficiency. 2015 Biol. Blood Marrow Transplant. pmid:25636378
Schoettler M et al. Treatment and outcomes of immune cytopenias following solid organ transplant in children. 2015 Pediatr Blood Cancer pmid:25308853
Joneja U and Uppal G Pseudo-Pelger-Huët anomaly in a patient on tacrolimus. 2015 Blood pmid:26371350
Ustundag UV et al. The effects of tacrolimus on the activity and expression of tissue factor in the rat ovary with ischemia-reperfusion induced injury. 2015 Reprod Biol pmid:26370456
Mok CC Mycophenolate mofetil for lupus nephritis: an update. 2015 Expert Rev Clin Immunol pmid:26364748
Gao L and Sun Y In vitro interactions of antifungal agents and tacrolimus against Aspergillus biofilms. 2015 Antimicrob. Agents Chemother. pmid:26303797
Kawahara T et al. Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1. 2015 Oncotarget pmid:25638160
Kita A et al. Imp2, the PSTPIP homolog in fission yeast, affects sensitivity to the immunosuppressant FK506 and membrane trafficking in fission yeast. 2015 Biochem. Biophys. Res. Commun. pmid:25580011
Cortina G et al. De novo tacrolimus-induced thrombotic microangiopathy in the early stage after renal transplantation successfully treated with conversion to everolimus. 2015 Pediatr. Nephrol. pmid:25577332
Pape E et al. Management of Tacrolimus-Telaprevir Drug-Drug Interaction in a Liver Transplant Patient With Hepatitis C Virus: Practical Considerations. 2015 Transplantation pmid:26308424
Iwamoto T et al. Effect of Genetic Polymorphism of CYP3A5 and CYP2C19 and Concomitant Use of Voriconazole on Blood Tacrolimus Concentration in Patients Receiving Hematopoietic Stem Cell Transplantation. 2015 Ther Drug Monit pmid:25565672
Ruiz J et al. Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation. 2015 Int J Mol Sci pmid:26307985
Nelson R et al. Sirolimus, tacrolimus and antithymocyte globulin as GVHD prophylaxis in HLA-mismatched unrelated donor hematopoietic cell transplantation: a single institution experience. 2015 Bone Marrow Transplant. pmid:26301969
Reddy YN et al. Is there a genetic predisposition to new-onset diabetes after kidney transplantation? 2015 Saudi J Kidney Dis Transpl pmid:26586047
Bauters T et al. Practical considerations in the use of intravenous tacrolimus in hematopoietic stem cell transplantation patients. 2015 J Oncol Pharm Pract pmid:24748582
Yu Y et al. Investigation into the interchangeability of generic formulations using immunosuppressants and a broad selection of medicines. 2015 Eur. J. Clin. Pharmacol. pmid:26062932
Millner L et al. A clinical approach to solving discrepancies in therapeutic drug monitoring results for patients on sirolimus or tacrolimus: Towards personalized medicine, immunosuppression and pharmacogenomics. 2015 Clin. Chim. Acta pmid:26232156
Tornatore KM et al. Influence of sex and race on mycophenolic acid pharmacokinetics in stable African American and Caucasian renal transplant recipients. 2015 Clin Pharmacokinet pmid:25511793
Li JL et al. Interactive effects of CYP3A4, CYP3A5, MDR1 and NR1I2 polymorphisms on tracrolimus trough concentrations in early postrenal transplant recipients. 2015 Pharmacogenomics pmid:26228923
Zhu LQ et al. Posterior reversible encephalopathy syndrome and graft-versus-host disease after liver transplantation: a case report and review of the literature. 2015 Int J Clin Pharmacol Ther pmid:26227100
Zhang JJ et al. The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipients. 2015 Int J Clin Pharmacol Ther pmid:26227094
Peake RW et al. Multicenter evaluation of the thermo scientific prelude for measurement of immunosuppressant drugs using sample preparation liquid chromatography-tandem mass spectrometry. 2015 Ther Drug Monit pmid:25072947
Mettang T and Kremer AE Uremic pruritus. 2015 Kidney Int. pmid:24402092
Takeuchi S et al. Pruritus of patients with atopic dermatitis in daily life and their experience of therapeutic effects: results of a web-based questionnaire survey. 2015 Br. J. Dermatol. pmid:25421804
Kabrine M and Laraba-Djebari F Immunomodulatory and protective properties of tacrolimus in experimental scorpion envenomation. 2014 Jan-Mar Int J Immunopathol Pharmacol pmid:24674680
Wang C and Lin A Efficacy of topical calcineurin inhibitors in psoriasis. 2014 Jan-Feb J Cutan Med Surg pmid:24377467
Feito-Rodríguez M et al. Bacterial vaginosis in the context of lichen sclerosus in a prepubertal girl. 2014 Jan-Feb Pediatr Dermatol pmid:24125016
Veisa G et al. The importance of renal biopsy in the management of renal transplantation. 2014 Apr-Jun Rev Med Chir Soc Med Nat Iasi pmid:25076703
Naganuma M et al. [Clinical relevance of tacrolimus trough levels in outpatients with active ulcerative colitis]. 2014 Nihon Shokakibyo Gakkai Zasshi pmid:24500317
Sahin S et al. The protective effects of tacrolimus on rat uteri exposed to ischemia-reperfusion injury: a biochemical and histopathologic evaluation. 2014 Fertil. Steril. pmid:24502894
Pereira MJ et al. Cyclosporine A and tacrolimus reduce the amount of GLUT4 at the cell surface in human adipocytes: increased endocytosis as a potential mechanism for the diabetogenic effects of immunosuppressive agents. 2014 J. Clin. Endocrinol. Metab. pmid:25004245
Iwanami M et al. [Orbital apex syndrome due to relapse during steroid tapering in a patient with MPO-ANCA-positive IgG4-related hypertrophic pachymeningitis]. 2014 Rinsho Shinkeigaku pmid:24429649
Masson P et al. Belatacept for kidney transplant recipients. 2014 Cochrane Database Syst Rev pmid:25416857
Lalić J et al. Immunosuppressive medication adherence in kidney transplant patients. 2014 Med Princ Pract pmid:24923773
Schlegel A et al. Hypothermic Oxygenated Perfusion (HOPE) downregulates the immune response in a rat model of liver transplantation. 2014 Ann. Surg. pmid:25243553
Kujawski S et al. Calcineurin regulates coordinated outgrowth of zebrafish regenerating fins. 2014 Dev. Cell pmid:24561038
Eguchi R et al. Recombinant human soluble thrombomodulin attenuates FK506-induced endothelial dysfunction through prevention of Akt inactivation. 2014 Exp. Cell Res. pmid:24582967
Hao JC et al. Effect of low-dose tacrolimus with mycophenolate mofetil on renal function following liver transplantation. 2014 World J. Gastroenterol. pmid:25170222
Vattemi G et al. Polymyositis in solid organ transplant recipients receiving tacrolimus. 2014 J. Neurol. Sci. pmid:25130930
Narabayashi K et al. Oral tacrolimus for megacolon in patients with severe ulcerative colitis. 2014 Intern. Med. pmid:25130105
Calo S et al. Antifungal drug resistance evoked via RNAi-dependent epimutations. 2014 Nature pmid:25079329
Chen SR et al. Calcineurin inhibitor induces pain hypersensitivity by potentiating pre- and postsynaptic NMDA receptor activity in spinal cords. 2014 J. Physiol. (Lond.) pmid:24081160
Han JS et al. Tacrolimus 0.1% ointment in the treatment of allergic contact dermatitis: a new approach. 2014 Int. J. Dermatol. pmid:25070257
Hara H et al. Hematopoietic chimerism following allotransplantation of the spleen, splenocytes or kidney in pigs. 2014 Transpl. Immunol. pmid:25245436
Kanyshkova T et al. Regionally specific expression of high-voltage-activated calcium channels in thalamic nuclei of epileptic and non-epileptic rats. 2014 Mol. Cell. Neurosci. pmid:24914823
Song L et al. Effects of ASKP1240 combined with tacrolimus or mycophenolate mofetil on renal allograft survival in Cynomolgus monkeys. 2014 Transplantation pmid:24992357
Wang Z et al. Influence of TLR4 rs1927907 locus polymorphisms on tacrolimus pharmacokinetics in the early stage after liver transplantation. 2014 Eur. J. Clin. Pharmacol. pmid:24820765
Akchurin OM et al. Medication adherence in the transition of adolescent kidney transplant recipients to the adult care. 2014 Pediatr Transplant pmid:24820521
Colom H et al. Pharmacokinetic modeling of enterohepatic circulation of mycophenolic acid in renal transplant recipients. 2014 Kidney Int. pmid:24402086
Castronovo G et al. The effect of nonsurgical periodontal treatment on the severity of drug-induced gingival overgrowth in transplant patients. 2014 Quintessence Int pmid:24389563
Yap DY et al. Long-term data on tacrolimus treatment in lupus nephritis. 2014 Rheumatology (Oxford) pmid:24996908
Varghese J et al. Tacrolimus-related adverse effects in liver transplant recipients: its association with trough concentrations. 2014 Indian J Gastroenterol pmid:24740447
Calabrese B et al. Activity-dependent dendritic spine shrinkage and growth involve downregulation of cofilin via distinct mechanisms. 2014 PLoS ONE pmid:24740405
Langers P et al. Limited sampling model for advanced mycophenolic acid therapeutic drug monitoring after liver transplantation. 2014 Ther Drug Monit pmid:24081208
Lee SK et al. Overexpression of the putative extracytoplasmic function sigma (σ) factor FujE enhances FK506 production in Streptomyces sp. strain KCCM 11116P. 2014 Can. J. Microbiol. pmid:24869633
da Cunha Filho RR et al. "Angular" plasma cell cheilitis. 2014 Dermatol. Online J. pmid:24656273
Nakamura A et al. Effects of elevated tacrolimus trough levels in association with infectious enteritis on graft function in renal transplant recipients. 2014 Transplant. Proc. pmid:24656020